Group One Trading’s RAPT Therapeutics RAPT Stock Holding History

Group One Trading’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,282	Closed	-$179K	–	8537
2025 Q4	$179K	Buy	5,282 +2,583	+96%	+$80.2K	﹤0.01%	4478
2025 Q3	$69.6K	Buy	+2,699	New	+$35.3K	﹤0.01%	5676
2025 Q1	–	Sell	-6,126	Closed	-$60.2K	–	8241
2024 Q4	$77.4K	Buy	6,126 +4,747	+344%	+$60.3K	﹤0.01%	4719
2024 Q3	$22.2K	Buy	+1,379	New	+$27.9K	﹤0.01%	5173
2022 Q3	–	Sell	-29	Closed	-$5.49K	–	8102
2022 Q2	$4K	Buy	+29	New	+$3.87K	﹤0.01%	7214
2021 Q2	–	Sell	-20	Closed	-$3.74K	–	8501
2021 Q1	$4K	Sell	20 -150	-88%	-$24.7K	﹤0.01%	7294
2020 Q4	$27K	Buy	+170	New	+$37K	﹤0.01%	5352

Group One Trading's RAPT Position: Q1 2026 in Review

Group One Trading sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 5,282 shares — an estimated $179K sold.

Group One Trading first reported a position in RAPT in Q4 2020 and held it in 7 quarters. The position peaked at $179K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Group One Trading reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 5,282 RAPT Therapeutics shares in Q1 2026, an estimated $179K.
Group One Trading first reported a position in RAPT Therapeutics in Q4 2020 and held it in 7 quarters.
Group One Trading's RAPT Therapeutics position peaked at $179K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.